|
|
|
Volumn 8, Issue 11, 2010, Pages 746-748
|
|
Advances in CML: The role of allogeneic hematopoietic stem cell transplantation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BUSULFAN;
CLOFARABINE;
FLUDARABINE;
IMATINIB;
LYMPHOCYTE ANTIBODY;
PROTEIN TYROSINE KINASE INHIBITOR;
THYMOCYTE ANTIBODY;
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION;
ARTICLE;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CHRONIC MYELOID LEUKEMIA;
COMORBIDITY;
DISEASE CLASSIFICATION;
DISEASE COURSE;
DISEASE FREE SURVIVAL;
DISEASE SEVERITY;
DOSE RESPONSE;
DRUG SAFETY;
GRAFT VERSUS HOST REACTION;
HUMAN;
INFECTION;
LOW DRUG DOSE;
MAINTENANCE THERAPY;
PATIENT CARE;
PATIENT SAFETY;
REDUCED INTENSITY CONDITIONING;
SURVIVAL RATE;
WHOLE BODY RADIATION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
TRANSPLANTATION CONDITIONING;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 78649955419
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (2)
|
